cobalt has been researched along with Diabetic Glomerulosclerosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Packer, M | 1 |
| Fasching, A; Friederich-Persson, M; Hansell, P; Liss, P; Nangaku, M; Nordquist, L; Palm, F; Shoji, K | 1 |
| Dan, T; Miyata, T | 1 |
| Ahn, SH; Han, KH; Han, SY; Kim, HS; Lee, YM; Sun, HK | 1 |
| Deshmukh, AB; Mishra, B; Patel, JK; Prajapati, AR | 1 |
| Izuhara, Y; Miyata, T; Nangaku, M; Ohtomo, S; Strihou, Cv; Takizawa, S | 1 |
1 review(s) available for cobalt and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics.
Topics: Basic Helix-Loop-Helix Transcription Factors; Cobalt; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Endoplasmic Reticulum Stress; Erythropoiesis; Fibrosis; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Kidney; Oxidative Stress; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
5 other study(ies) available for cobalt and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Activation of hypoxia-inducible factors prevents diabetic nephropathy.
Topics: Animals; Antioxidants; Cobalt; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Glomerular Filtration Rate; Hypoxia-Inducible Factor 1; Kidney; Male; Oxidative Stress; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Spin Labels | 2015 |
Inhibition of advanced glycation end products (AGEs): an implicit goal in clinical medicine for the treatment of diabetic nephropathy?
Topics: Animals; Caloric Restriction; Cobalt; Diabetic Nephropathies; Disease Models, Animal; Glycation End Products, Advanced; Hypoglycemic Agents; Hypoxia-Inducible Factor 1, alpha Subunit; Oxidative Stress; Rats; Treatment Outcome | 2008 |
Phosphodiesterase inhibitor improves renal tubulointerstitial hypoxia of the diabetic rat kidney.
Topics: Animals; Cell Line; Cobalt; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Gene Expression Regulation; Glucose; Glucose Transporter Type 1; Heme Oxygenase (Decyclizing); Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Tubules; Male; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Streptozocin; Time Factors; Vascular Endothelial Growth Factor A | 2012 |
Investigating the effect of CoCl2 administration on diabetic nephropathy and associated aortic dysfunction.
Topics: Animals; Aorta, Thoracic; Cobalt; Diabetic Nephropathies; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2012 |
Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model.
Topics: Animals; Antimutagenic Agents; Arginine; Basic Helix-Loop-Helix Transcription Factors; Blood Pressure; Blotting, Western; Chromatography, High Pressure Liquid; Cobalt; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Gene Expression; Glycation End Products, Advanced; Hypertension; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immediate-Early Proteins; Insulin-Like Growth Factor Binding Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Lysine; Male; NADPH Oxidases; Obesity; Oxidative Stress; Polymerase Chain Reaction; Rats; Rats, Inbred SHR; RNA, Messenger; Transforming Growth Factor beta | 2008 |